SE7408045L - Morfolinderivat - Google Patents

Morfolinderivat

Info

Publication number
SE7408045L
SE7408045L SE7408045A SE7408045A SE7408045L SE 7408045 L SE7408045 L SE 7408045L SE 7408045 A SE7408045 A SE 7408045A SE 7408045 A SE7408045 A SE 7408045A SE 7408045 L SE7408045 L SE 7408045L
Authority
SE
Sweden
Prior art keywords
morpholine derivatives
morpholine
derivatives
Prior art date
Application number
SE7408045A
Other languages
English (en)
Other versions
SE383884B (sv
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to SE7408045A priority Critical patent/SE383884B/sv
Publication of SE7408045L publication Critical patent/SE7408045L/sv
Publication of SE383884B publication Critical patent/SE383884B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SE7408045A 1974-06-18 1974-06-18 Sett att framstella morfolinderivat SE383884B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7408045A SE383884B (sv) 1974-06-18 1974-06-18 Sett att framstella morfolinderivat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7408045A SE383884B (sv) 1974-06-18 1974-06-18 Sett att framstella morfolinderivat

Publications (2)

Publication Number Publication Date
SE7408045L true SE7408045L (sv) 1975-12-19
SE383884B SE383884B (sv) 1976-04-05

Family

ID=20321473

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7408045A SE383884B (sv) 1974-06-18 1974-06-18 Sett att framstella morfolinderivat

Country Status (1)

Country Link
SE (1) SE383884B (sv)

Also Published As

Publication number Publication date
SE383884B (sv) 1976-04-05

Similar Documents

Publication Publication Date Title
SE428562C (sv) Forfarande for framstellning av purinderivat
BE830402A (fr) Derives polyniques
NO802720L (no) Benzofenon-derivater.
BR7502999A (pt) Esquema mostrador
DK524175A (da) Bendiazepinderivater
DK198675A (da) Morfolinderivater
SE7514087L (sv) Morfolinderivat
SE409641B (sv) Lopare for blixtlas
SE7510671L (sv) Bensofuranderivat
CU34293A (es) Derivados acilicos
SE7414622L (sv) Fenylpyridinamiderivat
DK234475A (da) Amidinhydrazonderivater
FR2293207A1 (fr) Derives de 3-formylcephem
SE7800301L (sv) Tioxantenderivat
DK325975A (da) Piperazinderivater
FR2280378A1 (fr) Derives de piperidinobutyrophenone
NL7500967A (nl) Dihydroanthraceen derivaten.
CU34406A (es) Nuevas bencilpirimidinas
SE7408045L (sv) Morfolinderivat
BE829522A (fr) Derives de benzazine
DK341775A (da) 7-methoxycephalosporinderivater
BE826521A (fr) Derives acyles
NL7503269A (nl) Thiobenzodiazepinederivaten.
DK534177A (da) Imidazo-diazepinderivater
DK264975A (da) Phenylderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7408045-8

Format of ref document f/p: F